Parkinsn's Email List Message

Posting to the Parkinsn List is a benefit of Subscription

[Message Prev][Message Next][Thread Prev][Thread Next][Message Index][Thread Index]

NEWS: Tantalizing Tidbit

Here is an precis of an article provided by my online NewsService.
Sorry, I'm too cheap to pay for an article which will be publically
available soon.
                Ron 50/2
****************************************************************
Roche Tasmar for Parkinson's disease will be available at end of February
following Jan. 29 approval; indication differs from that of Requip, Mirapex.
ROCHE TASMAR 200 MG T.I.D. REDUCES "OFF" TIME BY THREE HOURS from a
baseline of 5.9 hours, according to data from a U.S./Canadian study
included in labeling for the Parkinson's disease therapy approved Jan. 29.
 [Health News Daily, 819 words]
                                             PAY PER VIEW, $3.50
******************************************************************

Parkinsn's List Subject Index

Parkinsn's List Thread Index

Parkinsn's Archive Treasures Doctors, students, patients and caregivers find current Parkinson's information such as the Algorithm, Caregivers Handbook, and talks by respected Movement Disorder Specialists.

Mail converted by MHonArc 2.6.10
Site Hosting donated by He.net
&
Grant from The Parkinson Alliance